A detailed history of Veriti Management LLC transactions in Argenx Se stock. As of the latest transaction made, Veriti Management LLC holds 1,558 shares of ARGX stock, worth $927,913. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,558
Previous 1,911 18.47%
Holding current value
$927,913
Previous $821,000 2.8%
% of portfolio
0.05%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$434.22 - $551.9 $153,279 - $194,820
-353 Reduced 18.47%
1,558 $844,000
Q2 2024

Aug 02, 2024

BUY
$356.01 - $451.55 $33,108 - $41,994
93 Added 5.12%
1,911 $821,000
Q1 2024

Apr 19, 2024

BUY
$356.95 - $413.29 $56,755 - $65,713
159 Added 9.58%
1,818 $715,000
Q4 2023

Feb 05, 2024

BUY
$338.91 - $506.01 $165,726 - $247,438
489 Added 41.79%
1,659 $631,000
Q3 2023

Oct 27, 2023

BUY
$369.35 - $548.43 $79,779 - $118,460
216 Added 22.64%
1,170 $575,000
Q2 2023

Jul 13, 2023

BUY
$360.14 - $422.58 $1,800 - $2,112
5 Added 0.53%
954 $371,000
Q1 2023

Apr 26, 2023

SELL
$334.23 - $403.65 $8,021 - $9,687
-24 Reduced 2.47%
949 $353,000
Q4 2022

Jan 20, 2023

BUY
$342.17 - $402.31 $65,696 - $77,243
192 Added 24.58%
973 $0
Q3 2022

Oct 26, 2022

BUY
$343.2 - $395.75 $24,367 - $28,098
71 Added 10.0%
781 $276,000
Q2 2022

Jul 18, 2022

BUY
$269.58 - $378.88 $7,278 - $10,229
27 Added 3.95%
710 $269,000
Q1 2022

Apr 11, 2022

BUY
$254.45 - $351.06 $173,789 - $239,773
683 New
683 $215,000
Q4 2021

Jan 19, 2022

SELL
$272.01 - $353.03 $180,614 - $234,411
-664 Closed
0 $0
Q3 2021

Oct 08, 2021

SELL
$295.0 - $350.58 $191,455 - $227,526
-649 Reduced 49.43%
664 $201,000
Q2 2021

Jul 13, 2021

BUY
$257.11 - $319.92 $337,585 - $420,054
1,313 New
1,313 $395,000
Q1 2021

Apr 14, 2021

SELL
$268.3 - $380.31 $50,977 - $72,258
-190 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$248.13 - $308.36 $47,144 - $58,588
190 New
190 $56,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.